Identifying Hypercortisolism in Patients with Resistant Diabetes : Episode 11

Opinion

Video

May 28, 2024

Choosing Between Medical and Surgical Options for Hypercortisolism

Author(s):

Hanford Yau, MD ,Ralph DeFronzo, MD

Medical professionals discuss their ideal patients for surgery, and who would be best suited for pharmacologic intervention.

EP: 1.Defining Resistant Diabetes

EP: 2.Differentiating Medication Non-Adherence From Underlying Comorbidities

EP: 3.Barriers to Accessing New Anti-Diabetes Medications

EP: 4.Suspecting Hypercortisolism in Patients With Resistant Diabetes

EP: 5.Testing for Hypercortisolism

EP: 6.Patient Subgroups With a Higher Prevalence of Hypercortisolism

EP: 7.Evolving Perception of Autonomous Adrenal Hypercortisolism

EP: 8.Pathophysiology of Hypercortisolism

EP: 9.Need to Address Underlying Hypercortisolism

EP: 10.Approaching Treatment in Hypercortisolism

EP: 11.Choosing Between Medical and Surgical Options for Hypercortisolism

EP: 12.Long-Term Outcomes for Patients Treated for Hypercortisolism

Related Videos

4 experts are featured in this series.

4 experts are featured in this series.

4 experts are featured in this series.

4 experts are featured in this series.

Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego

Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn

Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute

Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.